Format

Send to

Choose Destination
See comment in PubMed Commons below
Cell Signal. 2015 May;27(5):899-907. doi: 10.1016/j.cellsig.2015.02.001. Epub 2015 Feb 17.

GNA15 expression in small intestinal neuroendocrine neoplasia: functional and signalling pathway analyses.

Author information

1
Gastrointestinal Pathobiology Research Group, Yale University School of Medicine, New Haven, CT 06520-8062, USA; Department of Surgery, Laboratory of Translational Surgery, LURM, Hospital of G.B. Rossi, University of Verona, Piazzale L.A. Scuro, IT-37134 Verona, Italy.
2
Gastrointestinal Pathobiology Research Group, Yale University School of Medicine, New Haven, CT 06520-8062, USA.
3
Institute of Pathophysiology and Immunology, Centre for Molecular Medicine, Medical University of Graz, Graz, Austria.
4
Department of Surgery, Laboratory of Translational Surgery, LURM, Hospital of G.B. Rossi, University of Verona, Piazzale L.A. Scuro, IT-37134 Verona, Italy.
5
Gastrointestinal Pathobiology Research Group, Yale University School of Medicine, New Haven, CT 06520-8062, USA. Electronic address: mark.kidd@yale.edu.

Abstract

Gastroenteropancreatic neuroendocrine neoplasia (GEP-NEN) comprises a heterogeneous group of tumours that exhibit widely divergent biological behaviour. The identification of new targetable GPCR-pathways involved in regulating cell function could help to identify new therapeutic strategies. We assessed the function of a haematopoietic stem cell heterotrimeric G-protein, Gα15, in gut neuroendocrine cell models and examined the clinical implications of its over expression. Functional assays were undertaken to define the role of GNA15 in the small intestinal NEN cell line KRJ-I and in clinical samples from small intestinal NENs using quantitative polymerase chain reaction, western blot, proliferation and apoptosis assays, immunoprecipitation, immunohistochemistry (IHC) and automated quantitative analysis (AQUA). GNA15 was not expressed in normal neuroendocrine cells but was overexpressed in GEP-NEN cell lines. In KRJ-I cells, decreased expression of GNA15 was associated with inhibition of proliferation, activation of apoptosis and differential effects on pro-proliferative ERK, NFκB and Akt pathway signalling. Moreover, Gα15 was demonstrated to couple to the ß1 adrenergic receptor and modulated proliferative signals through this GPCR. Transcript and protein levels of GNA15 were significantly elevated in primary and metastatic tumours compared to normal mucosa and were particularly increased in low Ki-67 expressing tumours. IHC and AQUA revealed that a higher Gα15 expression was associated with a poorer survival. GNA15 may have a pathobiological role in SI-NENs. Targeting this signalling mediator could provide an opportunity for the development of new therapeutic strategies for this tumour type.

KEYWORDS:

G protein; GNA15; Gα15; KRJ-I cell line; Small intestinal neuroendocrine neoplasia; ß(1) adrenergic receptor

PMID:
25701539
DOI:
10.1016/j.cellsig.2015.02.001
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center